OUR VISION:
Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Exact Sciences Highlights CMS Advisory Panel's Unanimous Vote to Maintain Medicare Reimbursement Rate for Cologuard®

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously to maintain Medicare's current crosswalk pricing ($492.72) for Cologuard. The 11-0 vote, including one abstention, came after the Clinical Lab Fee Schedule's July 16, 2015 public...Read more

View Renderings of Our Proposed Downtown Madison Headquarters

Nearly four months ago, JDS Development, a collaboration of The Hammes Co. and Majestic Realtyannounced it had submitted a proposal to the City of Madison for the Judge Doyle Square project. This project brings together world-class architecture in a mixed-use setting and could relocate Exact Sciences to downtown Madison.  On Monday, the City Council’s Board of Estimates will...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More